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Abstract
Pluripotent stem cell lines have been generated in several domestic animal species; however, these lines traditionally show
poor self-renewal and differentiation. Using canine embryonic stem cell (cESC) lines previously shown to have sufficient self-
renewal capacity and potency, we generated and compared canine neural stem cell (cNSC) lines derived by lineage
selection with epidermal growth factor (EGF) or Noggin along the neural default differentiation pathway, or by directed
differentiation with retinoic acid (RA)-induced floating sphere assay. Lineage selection produced large populations of SOX2+
neural stem/progenitor cell populations and neuronal derivatives while directed differentiation produced few and improper
neuronal derivatives. Primary canine neural lines were generated from fetal tissue and used as a positive control for
differentiation and electrophysiology. Differentiation of EGF- and Noggin-directed cNSC lines in N2B27 with low-dose
growth factors (BDNF/NT-3 or PDGFaa) produced phenotypes equivalent to primary canine neural cells including 3CB2+
radial progenitors, MOSP+ glia restricted precursors, VIM+/GFAP+ astrocytes, and TUBB3+/MAP2+/NFH+/SYN+ neurons.
Conversely, induction with RA and neuronal differentiation produced inadequate putative neurons for further study, even
though appropriate neuronal gene expression profiles were observed by RT-PCR (including Nestin, TUBB3, PSD95, STX1A,
SYNPR, MAP2). Co-culture of cESC-derived neurons with primary canine fetal cells on canine astrocytes was used to test
functional maturity of putative neurons. Canine ESC-derived neurons received functional GABAA- and AMPA-receptor
mediated synaptic input, but only when co-cultured with primary neurons. This study presents established neural stem/
progenitor cell populations and functional neural derivatives in the dog, providing the proof-of-concept required to
translate stem cell transplantation strategies into a clinically relevant animal model.
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Introduction
Cell-based therapeutics has received incredible interest for
treating central nervous system diseases, and have been applied in
many models of spinal cord injury (SCI) [1]. Cell transplantation
strategies must be validated as safe and efficacious in preclinical
models before their translation to humans. Unfortunately, several
human clinical trials for CNS disorders have failed to show
functional benefits, even after the intervention has shown
significant, meaningful recovery in rodent models. This gap in
translation has been seen with putative treatments for stroke,
Alzheimer’s disease and SCI [2,3,4,5,6,7]. In light of this, many
researchers have called for the development of large animal
models to test preclinical trials for CNS disease, including SCI
[1,8,9,10]. The domestic dog has the greatest parity to humans in
genetic diseases [11] with over 220 common genetic diseases (the
Rhesus monkey boasts 5). Additionally, expert veterinary care
offers pre- and post-operative assessment, real-time referral centre
setting, treatment of spontaneous injury, and accurate extrapola-
tion to human treatment trajectories. These factors have
motivated scientists to call for canine cell transplantation models
of SCI [12,13].
Stem cell grafts have been generated for canine transplantation
strategies with some myelinating cells types more thoroughly
studied than in mice or humans [14,15]. To date, strategies have
been developed for canine SCI using mesenchymal stromal cells
[16,17]; autologous Schwann cells and olfactory ensheathing cells,
including a phase I trial [18,19]; and, human immortalized neural
stem cells (NSCs) [20,21]. While transplanting human-derived
cells in canine models is valuable, it does not allow for testing and
developing autologous or induced pluripotent stem cell (iPSC)
transplantation in large animal models. Clinical relevance of the
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19768canine platform is further amplified given that dogs and humans
share a common environment, leading to analogous SCI from
motor vehicle collisions and disc degeneration [22,23]. This allows
for synergy between laboratory concept and clinical application
with real-time realization.
Evaluating stem cell-derived transplantation in pre-human trials
requires comparable protocols of isolating, manipulating and
introducing graft tissue generated from pluripotent cell lines. To
date, there have been very few self-renewing ESC lines generated
from non-primate, non-rodent species [9], none of which have
been shown capable of producing functional derivatives. Canine
ESC lines have been established [24,25,26], however, proper
manipulation of these cells to produce operative cell types has not
been reported. Repair of the CNS will require neurons or
oligodendroglial cells produced, preferably, from autologous
sources. Reynolds and Weiss [27] were the first to isolate neural
stem cells (NSCs) from fetal mice, using basic fibroblast growth
factor (bFGF) and epidermal growth factor (EGF) to culture NSCs
in a neurosphere (NS) assay. Definitive proof of neurogenesis was
shown when electrophysiology was used to prove NSC-neurons
from rodents and humans integrated into host tissue, and were
synaptically competent [28,29].
Neural stem cells can also be grown efficiently in monolayers,
without cell-cell niche interactions in spheres, using the same EGF
signaling to specify the neural lineage [30]. Human ESCs and
iPSCs can also be restricted to the neural lineage by the
administration of Noggin to repress BMP signaling [31,32].
Furthermore, it has been shown that human ESCs maintained in
the absence of mitogens and exogenous signals select the neural
lineage fate, causing neural selection to be referred to as the
default pathway [33]. This discovery has led to efficient and
scalable production of purified NSC populations through lineage
selection, avoiding previous methods that employed high-dose
growth factors and mitogens such as retinoic acid (RA) [34].
Although multi-stage RA-based protocols are still used by several
labs, there is controversy as to whether these protocols should be
used to differentiate pluripotent and mesenchymal cells to neural
fates [35,36,37,38]. Nonetheless, transplantation of NSCs and glia-
restricted precursors has been shown to greatly improve motor and
sensory function in rats following SCI, and should be investigated
further [39,40,41].
Here, we present NSC and primary fetal cerebral lines
established in the dog. Canine (c)ESC-derived NSCs and primary
lines were used to generate populations of neural progenitors and
functional neurons. We used two types of cESC lines, derived from
blastocyst explants that exhibit a neural default (OVC.EX), or
derived from immunodissection of the ICM that do not exhibit a
neural default (OVC.ID) [24]. We show that Noggin and EGF
lineage selection of OVC.EX lines produces robust neural
progenitors as well as large populations of mature neurons that
exhibit proper immunophenotypes and spontaneous synaptic
activity. We then tested lineage selection against directed neural
differentiation using the non-neural OVC.ID lines and a standard
RA-based floating sphere assay. The RA-based differentiation
produced appropriate expression profiles; however, it did not
produce neuronal morphology or sufficient number of putative
neurons for analysis. To our knowledge, this is the first report of
NSCs, primary fetal lines, and functional neurons derived in a
domestic species. The domestic dog is an optimal model for the
next phase of pre-human trials in SCI due to the availability of
expert veterinary facilities, parity with human genetics and disease,
and trauma occurring in shared environments [13]. By developing
protocols to generate and manipulate potent cNSC lines, we hope
to move cell transplantation to the veterinary centre and create
clinical pre-human models of CNS damage and traumatic spinal
cord injury.
Results
Canine explant (OVC.EX) ESC lines exhibit a neural
default
To determine the neural capacity of canine ESC lines, we used
cell lines from explant (OVC.EX.4, 5, 7) and immunodissected
(OVC.ID.20, 21, 23) embryos that we previously showed to be
undifferentiated, self-renewing and pluripotent [24]. When
cultured in LIF and bFGF, these cell lines produce tightly packed,
flat colonies (Fig. 1A,B) that express ESC transcription factors
OCT4 and SOX2 (Fig. 1C,D), surface glycoproteins SSEA3,
SSEA4 and TRA-1-81 (Fig. 1E–G) and ESC niche-related
receptor FGFR2 [42] (Fig. 1H). Canine ESC colonies from
explant lines rapidly differentiate and exhibit outgrowths of bipolar
cells when grown in serum but without LIF, FGF2 or MEF feeders
for 1 week (Fig. 1I). These colonies produce diffuse monolayers of
migrating cells by 3 weeks (Fig. 1J), and derive cells with multiple
MAP2+ processes by 4 weeks (Fig. 1K, L).
RA-induced differentiation generates incomplete neural
determination from immunodissected (OVC.ID; non-
neural default) cESC lines
We subsequently used cESC lines derived by immundissection
(OVC.ID) that do not exhibit default differentiation into neural
lineages [24] to evaluate the effectiveness of producing competent
neural precursor cells through factor-induced differentiation.
Using the five-stage RA-based differentiation protocol that was
developed before the advent of the neural default pathway [33,34],
we tested the stepwise expression of neural genes and proteins
using Real-time qRT-PCR and immunocytochemistry. OCT4
was highly expressed in OVC.ID colonies; however, OCT4 was
down-regulated between 5 d embryoid body (EB) and adherent-
EB (Fn/ITS plated EB) by 18-fold (p,0.01), and abrogated upon
further differentiation (Fig. 2A). Concurrently, stage-specific
regulation of neuronal genes mimicked neuronal development
with immature (Nestin) and more mature (TUBB3) neural cell
types showing upregulation and peak at appropriate time points
for neurosphere (NS) and putative neuron (Nr) stages. Differen-
tiating cells also exhibit a high expression of MAP2 and TUBB3
protein from the adherent-EB stage onward (Fig. 2B–E). Mature
neuronal cytoskeletal and synaptic genes were similarly expressed
in neurospheres and putative neurons, indicating differentiated
cells are mature neuronal derivatives (Fig. 2F).
In spite of this, the putative neurons produced by a RA-based
induction protocol did not exhibit appropriate processes, cell-cell
connections, or dense networks (Fig. 2E). In fact, the putative
neurons could not be produced in sufficient numbers to properly
perform co-culture and electrophysiology assays.
Primary astrocytes, neurons, and cESC-derived neurons
from explant-generated cESC lines
Primary cell lines were established to model canine neural
development and verify cESC differentiation (OVC.EX lines).
Primary cerebral cells were isolated from canine fetal whole
cerebral tissue at 6 weeks of gestation. Approximately 5610
4 cells/
cm
2 were plated on coverslips coated with poly-D-lysine and
laminin in media designed to selectively propagate either astroglia
(ASM: astrocyte selection media) or neurons (N2B27 [43]). By day
5, spindle-shaped cells with short processes proliferated in ASM,
which continued to select predominantly flat, bipolar cells (Fig. 3Ai,
Functional Neurons from Canine ESCs
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contiguous, flat monolayers (Fig. 3Aiii). These astrocytes produced
confluent layers up to at least P7 after freeze-thaw (n=3), allowing
easy use for feeder layers in co-culture experiments. Culture of
dissociated tissue in N2B27 neuronal selection media produced
thin and arborized bipolar cells with apparent somas (Fig. 3Bi).
These populations were proliferative, and increased in numbers
without becoming flattened or astrocyte-like (Fig. 3Bii). Neurons
with evident interactions were seen by day 19, which increased in
network size and complexity thereafter (Fig. 3Biii).
To establish viable canine neural stem/progenitor cells (cNSC)
from cESCs, we adopted a lineage-selection approach. Noggin
and EGF block or circumvent BMP signaling, and efficiently direct
towards a neural lineage fate in human and mouse ESCs
[31,32,44,45,46]. Canine ESC lines generated from explant
cultures (OVC.EX.4, 5, 7) were directed to neural lineage
restriction with exposure to 20 ng/mL EGF or 50 ng/mL Noggin
while in monolayer culture. After passaging cESC cultures twice in
respective treatments, bipolar putative cNSCs were seen in
isolation and in colonies (Fig. 3Ci). Proliferation and cell migration
of cNSC populations was evident by passage (P)2 (Fig. 3Cii).
Accordingly, expanded populations of highly dense neuronal cells
possessed long, arborized neuron-like processes with domed somas
indicative of neuron specification (Fig. 3Ciii).
Canine ESC-derived NSC colonies are EGF and NOGGIN
responsive
Noggin- and EGF-directed neuralization established similar
cNSC colonies from OVC.EX lines by P4, consisting of tightly
packed SOX2+ neural stem cells (Fig. 4A, C) with peripheral
outgrowths of migrating progenitors (Fig. 4B, D). Upon continued
migration from parental colonies, cNSCs revealed increasing
neuronal phenotype with multiple MAP2+/TUBB3+ processes
and reduced SOX2 expression (Fig. 4B, D; data not shown).
Canine NSC colonies were easily maintained upon repeated
passaging in monolayers (Fig. 4, 5B). While there were few
differences between EGF- and Noggin-treated cNSC lines, EGF
groups exhibited less compact colonies with higher outgrowth of
compact cells, where Noggin groups exhibited more SOX2+ dense
colonies with a higher degree of arborization in migrating progeny
(Fig. 4C, D).
Primary and cNSC lines produce comparable and robust
neural derivatives
Explant cells from cNSCs (OVC.EX lines) could be maintained
in monolayers up to and beyond P6 while retaining SOX2+
expression (Fig. 5A, B) and glia and neuronal potential. To
determine differentiation capacity, cNSC lines were taken at P4
Figure 1. Canine ESCs express appropriate markers and neural lineage default differentiation. Canine ESCs derived from whole embryo
explants cultured on MEFs in the presence of LIF and bFGF exhibit tightly packed, flat human ESC-like colonies (A, B), and express OCT4 (C), SOX2 (D),
ESC surface markers SSEA 3 (E), SSEA4 (F), Tra-1-81 (G) and FGFR2 (H). Expression of ESC makers was not seen in MEF feeder cells (arrowhead, C–H).
Upon removal of LIF/bFGF and addition of 10% knock-out serum, cESC colonies rapidly differentiate (I) with outgrowths of radial cells at weeks 2–3
(J), which produce neural morphologies at 4 weeks (K) that express neural-specific protein MAP2 (L). DAPI was used as nuclear counterstain (blue).
Scale bar = 100 mm. Abbreviations: cESC, canine embryonic stem cell; MEF, mouse embryonic fibroblast; Wk, week.
doi:10.1371/journal.pone.0019768.g001
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assays. Bipolar progenitor cell aggregates were produced within 1
week that resembled neural rosettes with radial progenitor-like
cells [47] that express the radial glia marker 3CB2 (Fig. 5C, D).
Radial progenitors persisted only when propagated on MEF
feeders in N2B27 media supplemented with bFGF, but could be
transiently seen in ASM, or N2B27 without bFGF (data not
shown). Primary lines exhibited a more densely packed and
elongated rosette structures than cNSC lines. Culturing cNSCs in
low-dose PDGFaa/T3 for 3 weeks produced GFAP+ and Myelin/
Oligodendrocyte specific protein (MOSP)+ cells consistent with
astrocytes and oligodendrocyte precursor cells, respectively
(Fig. 5E, F). Culture in N2B27, on the other hand, rapidly
produced mixed neural fates, including GFAP+ stellate cells
resembling various astrocytes, and neuronal cells with elongated
TUBB3+ processes (Fig. 5G, H).
Figure 2. Induced differentiation generates incompetent neural cells from immunodissection-generated cESC lines. Canine ESCs
without neural predisposition (OVC.ID lines) produce expected expression profiles during RA-induced differentiation (A–D), but exhibit improper
neuronal phenotypes (E) even while expressing mature neuronal genes (F). (A) Upon neural induction, pluripotency gene expression (OCT4) is down-
regulated and proper temporal upregulation of early (Nestin) and late (TUBB3) neural genes occurs throughout progressive stages of differentiation.
(B) LIF removal allows embryoid bodies (EBs) to form from OVC.ID colonies. (C, D) Treatment with RA and adherence to Fn/ITS substrates induces a
high proportion of MAP2+ neural cells, leading to neurosphere (NS) formation. (E) Culture in NT-3/NGF/BDNF-supplemented media allows cells to
grow out from NSs. These neural-like cells are sparse, and absent of neuronal processes or interactions, suggesting expression profiles are inadequate
to characterize putative progenitor populations. DAPI was used as nuclear counterstain (blue; C, E). Scale bar = 100 mm. *, p,0.05; **, p,0.01. Real-
time RT-PCR data was normalized to highest expression level per gene and calibrated with respect to GAPDH. (E) Lanes: L, molecular weight ladder; -,
negative control; NS, neurosphere; Nr, putative neuron. Abbreviations: ESC, embryonic stem cell; Fn, fibronectin; ITS, insulin/transferrin/selenium; RA,
retinoic acid.
doi:10.1371/journal.pone.0019768.g002
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cNSC-derived and primary astrocytes were trypsinized after 3
weeks of initial culture and plated on coated coverslips to
confluence. Putative neurons were co-cultured on astrocyte-seeded
coverslips and morphologically distinct neuronal-like cell types
arose within 3 weeks. Long, thin immature dendritic spines were
also seen at this time using MAP2-immunocytochemistry (Fig. 5I,
J). Evidence of functional morphological maturation was also seen,
as neurons exhibited NFH+ axons that contained synapsin (SYN)
positive synaptic vesicles along its length (Fig. 5K, L). Expression
of mature axonal and synaptic proteins persisted to 6 weeks, and
was present when neurons were grown in astrocyte co-culture with
or without addition of NT-3 and BDNF. Canine fetal astrocyte
and neuronal cell types could be produced with simple adaptation
of mouse- and human-based culture conditions [32], with both
primary and cESC-derived lines exhibiting equivalent potency and
cell maturity.
Co-cultured cNSC-derived neurons exhibit mature
synaptic physiology
To determine whether cNSC lines generate functional neurons,
we used whole cell voltage clamp analysis of spontaneous synaptic
events. Canine ESC-derived neurons were cultured with or
without primary cerebral neurons on astrocyte feeders for 6
weeks. Feeder layers were confluent, Vimentin+ primary or cESC-
derived astrocytes (Fig. 6A). Astrocytes and primary neurons were
labeled with Vybrant DiI membrane tag, and cESC-derived
neurons were distinguished with Vybrant DiO prior to co-culture
(Fig. 6B, C). All cESC-derived and primary neurons displaying
synaptic activity exhibited characteristic Na
+ and K
+–mediated
inward and outward currents when stepped from 2100 to 0 mV
in voltage-clamp mode (ie. were capable of generating action
potentials), while none of the non-active cells displayed these
characteristic currents. Inhibitory and excitatory synaptic activity
of canine neurons was not evident at one week of co-culture, but
increased to ,75% of recorded neurons by week 4, and declined
thereafter (Fig. 6D). Analysis of individual AMPA-R mediated
synaptic events in primary neurons alone or cESC-derived
neurons co-cultured with primary neurons showed functionally
equivalent membrane and synaptic characteristics (Fig. 6E).
Spontaneous excitatory and inhibitory currents recorded from
primary neurons or cESC-derived neurons co-cultured with
primary neurons were similar (Fig. 6F).
Quantitative characterization of synaptic activity at 4 weeks
revealed that primary neurons exhibit predominantly inhibitory
GABAergic synapses (Fig. 6G). Furthermore, the number of
functionally active canine ESC-derived cells was less than observed
in primary neurons, and canine ESC-derived neurons exhibited
predominantly excitatory glutamatergic synapses. Synaptic activity
in cESC-derived neurons was rarely seen in the absence of
primary neurons (n=1/15 individual recordings). These data
demonstrate that cells differentiated from cESC-NSCs require a
neuron specific supportive niche to fully differentiate into
functional neurons and integrate into established neural networks.
Discussion
Herein, we have presented cESC-derived NSC lines that are
capable of differentiating into functional neurons. We have also
shown that NSC lines can be derived from cESCs with simple
application of EGF or Noggin and maintained at sufficient culture
periods for expansion. Using cESC lines that do not exhibit a neural
default (OVC.ID), we then showed the RA-based neurosphere
differentiation protocol was not able to generate sufficient putative
neural cells from OVC.ID lines to test their synaptic physiology, and
was greatly inferior to N2B27 differentiation following lineage
Figure 3. Morphology of primary astrocyte, neuron, and cESC-derived cultures. Development of primary and cESC cultures shows
progressive differentiation through stem cell (i), progenitor (ii), and mature (iii) stages. (A) Primary fetal canine cells maintained in 10% serum (ASM)
generate confluent astrocyte-like monolayers. (B) Primary cells maintained in N2B27 media without mitogens generate increasing cell specification
and complexity of neuron-like cell networks. (C) Canine ESCs maintained in EGF without LIF/bFGF produces outgrowths of radial cells that develop
into specialized neuron-like networks. Scale bar = 100 mm. Abbreviations: ASM, astrocyte selection media; d, day; P, last day of passage indicated.
doi:10.1371/journal.pone.0019768.g003
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differentiation of OVC.EX lines; however, we have supported this
conclusion in a preceding study [24]. Finally, canine NSC and
primary fetal neural lines were demonstrated to be effectively
equivalentincapacityforderivingcelltypesthroughouteachstage of
neurodevelopment, from radial progenitor to mature neuron and
astrocyte. These results give proof-of-concept that progenitor cell
types can be produced in sufficient quantities for use in canine
therapeutic cell transplantation for SCI in veterinary medicine.
Theseresults expand upon neural differentiationstudiesof human
and mouse ESC lines and demonstrate that major signaling
pathways are indeed strongly conserved in other mammalian
species. Early studies of NSCs isolated from the mouse brain as
neurospheres used electrophysiology to demonstrate unequivocal
neuronal identity and full neural potency [28]. Our study used
similar yet updated methods to show unequivocal identity of cNSC-
derived cells. Human iPSC/ESCs and murine ESCs are most
efficiently driven to neural lineages using Noggin and EGF,
respectively [32,48]. Neural induction can be performed either in
classic neurosphere assay or in monolayer culture [27,31,33,49,50].
Induction using Noggin produced cESC-NSCs and their outgrowths
that are quite similar to hESC-NSCs; however, this is not surprising
since cESCs share colony morphology and surface antigen
characteristics with hESCs (SSEA12/SSEA3+/SSEA4+). In addi-
tion, this is the first demonstration of functional neural cell types
derived from canine fetal brains, a potential resource for future
studies on canine CNS disease physiology.
The failure of the RA-based protocol on non-neural OVC.ID
lines suggests that pluripotent cells—in some if not all species and
isolation methods—should not be forced into neural phenotypes
with high-dose mitogens to produce cells for transplant. The
seemingly appropriate expression profiles produced by RA-based
differentiation demonstrate that cellular activity, such as synaptic
activity, must be used to verify neural identity. Similar neural
phenotype mimicking has been previously shown, where culture in
high-dose neural growth factors was able to induce electric
waveforms and TUBB3 expression in dermal fibroblasts [51].
Transplanting precursors of myelinating cells is a proven
therapeutic strategy to ameliorate damage to the CNS. Robust
myelin production with subsequent recovery of sensorimotor
function and spinal cord electrophysiology has been demonstrated
in numerous mouse, rat and primate models of SCI
[1,39,40,41,52]. Differentiating mature oligodendrocytes could
be performed to validate the full gliogenic capacity of cNSC lines;
however, cNSC lines were shown to generate mature glia and
neurons. The ability of cNSCs to generate synaptically competent
Figure 4. EGF and Noggin are sufficient to generate NSCs from explant-generated cESC lines. Canine neural stem cell (cNSC) colonies are
rapidly generated following the addition of EGF (A, B) or Noggin (C, D) and removal of LIF and bFGF. Colonies retain SOX2 expression while exhibiting
large outgrowths of differentiating neural cells during lineage specification by EGF (B) or Noggin (D). Cells migrating from colony peripheries obtain
MAP2+ neural phenotypes among SOX2+ progenitor populations (B, D). All images were taken at P4. DAPI was used as nuclear counterstain (blue).
Scale bar = 100 mm. Abbreviation: P, passage.
doi:10.1371/journal.pone.0019768.g004
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potency. The inability of cNSC-derived neurons to produce
spontaneous synapses reliably without primary neurons suggests
that they require a stronger niche environment to create functional
networks. However, successful integration of cNSC-derived
neurons in the presence of primary neurons suggests that cNSC
lines are capable of integration with host spinal tissue. The
propensity of cNSCs to become neurons, astrocytes or oligoden-
drocytes upon transplantation in the injured cord is more vital,
and will require additional study.
Transplanted cells will also require proper labeling to ensure
sufficient follow-up. While MR and CT imaging modalities can
infer the presence of and response to grafted cells during follow-up
[16,23,53], self-inactivating lentivectors must be used to label
cNSCs with fluorescent proteins prior to cell delivery for
confirmation and analysis. Membrane-bound dyes such as DiO/
DiI can leach and fade over time, offering another impetus for
labeling with reporter proteins.
Lesion volumes resulting from spinal cord injury are incredibly
larger in humans than rodents, creating a great barrier to clinical
translation. This size disparity is further emphasized in many
rodent models of SCI that use thin incisions (hemisection), a
problematic tactic often used for studying cell types with lower
efficacy [1]. Rodent models are commonly used since the lesions
are small and well understood; however, pathophysiology is
similarly well known in the dog. Acute SCI due to vehicular
trauma and disc herniation is common in the domestic dog, which
has resulted in patent knowledge of glial scar formation,
histological changes, vascular remodeling, electrophysiology and
axonal inhibition [22,23].
Expert neurosurgical and medical management of SCI is
established at several veterinary referral centers. Consequently,
clinical trials of therapeutic stem cell delivery following real-world
contusion/compression SCI can be conducted that include
diagnostic imaging using MR, PET and CT, decompressive
surgical intervention, standardized assessment of ambulation,
sensation and resolution of neurologic sequelae [54]. This study
offers the methodology for scalable generation of cells that could
be used in the dog as a phase I/II clinical trial for veterinary
medical intervention or prehuman model of cell delivery. These
restricted precursors can be cryopreserved and provided as an off-
the-shelf product for use in veterinary trauma centers. Further-
more, successful generation of canine (c)iPSCs has been recently
reported [55], allowing the potential to create patient-specific
neural progenitors for cell delivery models in the dog. These ciPSC
lines were shown to express OCT4/ALP and expressed FLK-1,
Figure 5. Primary and cNSC lines differentiate into various neural progenitors and mature derivatives. Canine explant-generated ESCs
generate neural cells (right columns) equivalent to primary neural progenitors (left columns) when cultured in minimal media supplemented with
N2B27, NT-3/BDNF or PDGFaa/T3. (A, B) Bipolar SOX2+ neural progenitor cells quickly form following lineage selection. (C, D) Neural rosettes of
3CB2+ cells form within 1 week. (E, F) Culture in PDGFaa and T3 produce MOSP+/GFAP+ glial progenitors. (G, H) Culture in N2B27 produces mature
morphologies of GFAP+ astrocytes and TUBB3+ (Tuj1) neuronal cells. (I, J) Multipolar neurons exhibit extensive branching and MAP2+ dendritic spines
(arrowhead, inset). (K, L) Neurons also exhibit mature axons expressing 200 kDa heavy neurofilament (NFH) and punctate synapsin (SYN). Images
were taken following culture for 1 week (A–D, G–H) or 3 weeks (E–F, I–L), but all phenotypes were persistent to 6 weeks. DAPI was used as nuclear
counterstain (blue, C–L). Scale bar = 100 mm. Abbreviations: cNSC, cESC-derived canine neural stem cell; MOSP, Myelin/Oligodendrocyte specific
protein.
doi:10.1371/journal.pone.0019768.g005
Functional Neurons from Canine ESCs
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lines still require the proper molecular characterization in
concordance with accepted standards within the field [56,57].
Lineage restriction along the default differentiation pathway
efficiently produces neural derivatives from canine ESCs. The
NSCs and neurons produced by this method are physiologically
Figure 6. Co-culture on primary astrocytes produces functional cESC-derived neurons. When cultured on confluent layers of astrocytes
(A–C), canine stem cell-derived neurons grown with primary fetal neurons received functional inhibitory and/or excitatory synaptic inputs (E–H). (A, B)
Confluent layers of canine fetal astrocytes were labeled with DiI membrane dye, which was not visible at 488 nm (inset), and used as substrates for
co-culture. (C) Canine ESC-derived cells were labeled with DiO (arrow), which extended along the length of entire cell (arrowhead) within 24 hr, and
not to neighbouring cells. (D) Peak number of cells receiving synaptic input was reached at week 4 (characterized in G) with nearly 75% of sampled
cells receiving synaptic input. (E) Mean spontaneous excitatory postsynaptic currents in primary and cESC-derived neurons. Basic membrane
characteristics and rise-times of synaptic currents were equivalent between cells. (F) Primary and cESC-derived neurons exhibited spontaneous
inhibitory synaptic input after one week of co-culture. (G) At 3–4 weeks (shaded in D), primary fetal neurons exhibited predominantly inhibitory
GABAergic synaptic activity, while cESC-derived neurons displayed more glutamatergic synaptic activity, almost solely in the presence of primary
neurons. DAPI was used as nuclear counterstain (blue, A–C). Scale bar = 100 mm.
doi:10.1371/journal.pone.0019768.g006
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canine SCI. Beyond the inherent value to veterinary medicine, this
therapeutic strategy could create valuable clinical extrapolations
for human medicine. Medical practice is highly translatable
between large animals, as evidenced by the rapid adoption of
methylprednisolone for SCI in the dog based on arduous human
clinical trials [58]. It follows that safety and efficacy can be
clinically determined in large animal patients to inform future
clinical trials in human. While this is not a common platform used
to infer clinical safety for humans, the costs accrued by Geron
Corp (Menlo Park, CA, USA) using traditional preclinical
validation suggest that using large animal, non-experimental,
clinical platforms may be a much more pragmatic strategy.
Materials and Methods
Canine ESC culture
All embryos, fetal tissues and cells were obtained under strict
adherence to the guidelines of and approved by the Society for
Theriogenology, University of Guelph’s Animal Care Committee
and Canadian Council on Animal Care. Culture of canine ESCs
was performed as previously described [24] from morula and
blastocysts stage embryos (Approval No. 07R075). Briefly, cESC
lines produced from immunodissection of the ICM (OVC.ID) or
explant of whole blastocysts (OVC.EX) were plated on 10
5 cells/
cm
2 mitotically-arrested murine embryonic fibroblasts (MEF)
(ATCC, SCRC-1040) in ESC media that consisted of knock-out
(KO)-DMEM, 15% KO serum replacement, 4 ng/mL bFGF
(Invitrogen), 10 ng/mL hrLIF (Sigma), 15 mM adenosine, cyti-
dine, guanosine and uridine, 5 mM thymidine, 2 mM L-glutamine,
16non-essential amino acids, and 0.1 mM beta-mercaptoethanol.
Media was replaced by half every 2 days. Canine ESC cultures
were passaged every 4–7 days by mechanical dissociation in
30 mg/mL EDTA or 200 U/mL (0.1%) Collagenase IV, and
resuspended in a 1:1 mixture of fresh and conditioned media. For
serum-only spontaneous differentiation, cESC colonies from lines
OVC.EX were plated onto gelatinized flasks in cESC media,
without LIF or bFGF (termed basal media), and with 10% FBS for
up to 4 weeks before fixation for ICC staining. Assays were
performed on two to three clonal cell lines, immunodissected lines
(OVC.ID.20, 21 and 23) for induced RA-based differentiation and
explant lines (OVC.EX.4, 5 and 7) for EGF and Noggin lineage
selection, neural differentiation, and electrophysiology. No differ-
ences were observed between individual OVC.ID lines or
OVC.EX lines, and data within groups were pooled. Differences
between OVC.ID and OVC.EX lines to differentiation protocols,
i.e. inability to patch clamp OVC.ID putative neurons, and
inability of OVC.ID cNSC lines to reach P4, resulted in the
inability to functionally compare OVC.ID to OVC.ES lines.
Primary neural cell culture
To obtain fetal brain tissue, two bitches were inseminated and
surgical spays were performed at approximately 42 and 43 days of
gestation (Approval No. 07R075 under previously stated ethical
review boards). Whole uteruses were extracted and placed in PBS
on ice for transport. Fetal canine pups were removed by sterile
dissection without disturbing the placental ring. Tissues were
dissected and snapfrozenin liquid nitrogen or placed indissociation
media for cell culture. For primary cell cultures, cerebral tissues
were extracted whole using fine forceps with connective tissue (dura
and arachnoid maters) and vessels removed. Tissues were digested
in dissociation media consisting of 20 U/mL Papain (Sigma) in
basal culture media at 37uC for 30–45 min. Following dissociation,
cells were plated on 9 cm culture dishes at 4610
4 cells/cm
2 in
Neurobasal media supplemented with 16 N2B27 (all from
Invitrogen) and 0.5 mM L-glutamine for selection of primary
neurons (N2B27), or 10% ESC-qualified FBS, 3 mM L-glutamine
for primary astrocyte selection media (ASM).
Astrocyte-neuron co-culture
Following incubation in ASM for 13 days, astrocytes were
trypsinized and plated on 12 mm glass coverslips (Fisher) in 4-well
dishes at 4610
4 cells/cm
2 and cultured for 4–6 days to reach
confluence. Coverslips were pretreated for adherence with
0.1 mg/mL poly-D-lysine, aspirated and allowed to dry overnight,
then coated with 1 ng/mL laminin. To assess neural development
in vitro, primary neurons were plated onto astrocyte feeder layers
at 5610
4 cells/cm
2 and co-cultured for up to 8 weeks prior to
analysis with electrophysiology as described below. Control
cultures contained only primary astrocytes or primary neurons.
Astrocyte only, neuron only, and astrocyte plus neuron co-cultures
were fixed with 2% Paraformaldehyde (PFA) for ICC analysis of
protein expression at 1, 3 and 6 weeks.
Induced differentiation with RA
Using OVC.ID colonies, which do not spontaneously default to
the neural lineage, cESCs were directed to differentiate using early
neural induction protocols [34]. Culture on non-adherent
gelatinized dishes without feeders for 2 days produced embryoid
bodies (EB). These EBs were then cultured in basal ESC media
with 4 ng/mL bFGF, 10% FBS, and 5 mM Retinoic Acid (Sigma)
in non-adherent bacterial culture dishes for 8 days. Following a
subsequent 6 day culture in basal media with 1% ITS and 50 mg/
mL fibronectin (StemCell Technologies), neurospheres (NS) were
observed. To increase NS attachment, 10% FCS was added on the
first day only. For differentiation of terminal neurons (Nr),
neurospheres were plated at 5610
5 cells/cm
2 on poly-L-ornithine
and fibronectin-coated coverslips, and cultured for 14 days in ES
Basal Cult with 16 N2-A, 0.2 mM ascorbic acid (StemCell
Technologies), with supplementation of 10 ng/mL hrBDNF,
15 ng/mL hrNT-3, and 3 ng/mL hrGDNF supplements (R&D)
for the first 4 days. Cells were isolated for quantitative RT-PCR or
fixed for staining at stages EB, adherent EB, NS and Nr.
Neural selection with EGF or Noggin
To determine neural selection potential of cESCs, explant lines
(OVC.EX.4, 5 and 7) were grown on MEF feeders in 35 mm or 4-
well dishes in basal ESC media with bFGF, without LIF, for 14
days. Canine ESC cultures were then maintained in the presence
of 20 ng/mL FGF2 with either 20 ng/mL epidermal growth
factor (EGF) or 50 ng/mL Noggin (R&D) [88, 123] for 6 days.
Whole dishes were passaged using collagenase up to passage (P)4
and fixed for immunostaining at P1, P2 and P4. To isolate and
establish putative canine neural stem cell (NSC) and radial
progenitor cell (RPC) in monolayers, Noggin-restricted colonies
were isolated and passaged on MEF seeded 4-well dishes in N2B27
media with 20 ng/mL FGF2. In each group, media was replaced
every two to three days.
Directed differentiation of canine NSCs
Canine ESC-derived NSC/RPC cell lines from EGF and Noggin
treated groups were taken at P4 and cultured as described above in
N2B27 or ASM for differentiation of neurons and astrocytes,
respectively. Cells were then fixed and stained at 1, 3 and 6 weeks as
described for primary cell lines. Further supplementation of N2B27
media with 30 ng/mL NT-3 and 100 ng/mL BDNF was
performed for three groups, however no differences were seen in
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and data were pooled. For differentiation of oligodendrocyte
precursor cells (OPCs), primary fetal neural stem cells and
Noggin-restricted cESC-derived NSCs at P4 were cultured in
N2B27 media supplemented with 20 ng/mL bFGF and 10 ng/mL
PDGFaa (Peprotech) for 8 days, with 30 ng/mL T3 (Sigma) [59]
for an additional 6 days. Cells were fed and fixed as above.
Immunocytochemistry
Cells and neural derivatives were fixed in 4% or 2%
paraformaldehyde, respectively, for 15 min at room temperature
(RT) and washed 3 times in PBS. Embryoid bodies were fixed,
washed, maintained in 30% sucrose, snap frozen in OCT and
sectioned on a cryostat at 12 um thickness. Blocking and
permeabilization was performed with 0.1% Triton-X-100 and
10% normal donkey serum (NDS) or 10% normal goat serum
(NGS) for 45 min at RT. Cultures were incubated at 4uC
overnight with primary antibodies (Table S1) diluted in 10% NDS
or 10% NGS, 0.01% PBST (Tween-20 in phosphate-buffered
saline), then washed three times for 15 min with 0.1% PBST.
Appropriate secondary antibodies (1:500, all AlexaFluor from
Molecular Probes) were then incubated in 10% blocking solution
for 1 hr at RT. Nuclei were counterstained with 1 ng/mL DAPI
in PBST for 5 min, followed by three washes. Detergents (Triton-
X-100, NP40, Tween-20) were not included when staining against
cell surface antigens. Primary antibodies were replaced with PBS
for negative controls in each round of staining. Imaging was
performed on an Olympus X71 epifluorescent microscope using Q
Capture software (QImaging). Any and all alterations to global
brightness or contrast were first made to secondary-only control
files of equivalent imaging parameters to verify their acceptability.
Images were compiled and merged using Adobe Photoshop CS3.
RT-PCR
All RT-PCR was performed as previously described [24].
Briefly, total RNA from whole dishes or floating spheres was
isolated with RNeasy Micro kits (QIAGEN) according to
manufacturer’s directions using on-column DNase I digestion
and gDNA Eliminator Spin columns (QIAGEN). cDNA libraries
were generated using Superscript II First-strand systems (Invitro-
gen) in triplicate, including RT omitted controls, and with 1 uL of
100 ng/mL RNase A digestion. RNA/cDNA quality and quantity
was determined on a ND-1000 (NanoDrop Technologies). Intron-
spanning or flanking primer sets were designed using Primer3
online software (http://frodo.wi.mit.edu/) and Perl Primer
(http://perlprimer.sourceforge.net). Primers were used only if a
single amplicon of expected size were obtained, with sequencing
used to verify gene-specific identity (Table S2). Expression profiles
were examined at multiple stages including: 5 day EBs (EB),
adherent EBs at start of ITS/Fn treatment (Ad), neurospheres
(NS), and putative neurons (Nr). Amplification consisted of 27 or
30 cycles, found to be within linear range for all data, and negative
controls remained signal null until cycle 40.
Quantitative gene expression was determined with Real-time
qRT-PCR on a LightCycler 1.5, analyzed with 4.0 Exor software
(Roche). Gene-specific primer design and cDNA library creation
were performed as above. Reactions were performed with SYBR
green I DNA master mix (Roche) in 10 mL volumes. All Real-time
data was collated and corrected according to the Pfaffl-
based DDCp method [60,61,62] with relative expression = E(t)
‘
[Cp(t)(target-calibrator)]/E(r)
‘[Cp(r)(reference-calibrator)]. Three sam-
ples of each stage were analyzed in triplicate. Samples were
normalized to and validated with GAPDH, RPS18, and RNA
Pol II as housekeepers, with final data presented relative to
GAPDH [13].
Electrophysiology
For electrophysiologicalanalysisofsynapticactivity,fivegroupsof
cells were co-cultured on primary astrocyte feeder layers: primary
neurons; Noggin-treated cES cells with and without primary
neurons; EGF-treated cES cells with and without primary neurons.
Co-culture was performed on confluent astrocyte feeder layers as
described above. Primary cells and astrocyte feeders were labeled
with DiI (red; V-22885, Molecular probes), and cESC-derived
neurons were labeled with DiO (green; V-22886; Molecular probes)
to allow impartial distinction of cESC-derived and primary cells.
Whole cell patch-clamp recordings of primary neurons or cES cells
were performed as previously described [63]. Coverslips were
transferred to recording chambers where they were continuously
perfused with aCSF and visualized using infrared DIC microscopy
combined with epi-fluorescent. Tetrodotoxin (TTX) was added to
perfusion media while the cells were held at 280 mV in voltage-
clamp mode. To measure GABAA-R mediated events, cells were
gradually stepped to a holding potential of 0 mV and spontaneous
synaptic activity was recorded for 5 min. Following a 2 min wash-in
period GABAA-R mediated synaptic events were completely
blocked by perfusion of 10 uM bicuculline (Bic) and 50 uM
picrotoxin (Pic). Cells were then stepped to 280 mV, allowed to
recover for several minutes, and spontaneous AMPA-R mediated
synaptic event were recorded for 5 minutes. All excitatory synaptic
activity recorded in BicPic was inhibited using the AMPA/kainite
receptor antagonist NBQX (20 um). Network burst activity of
spontaneous polysynaptic AMPA-R mediated events was recorded
at 280 mV in BicPic without TTX in separate slices. Each
recording was analysed for the frequency, inter-event interval and
amplitude of AMPA- and GABAA-mediated synaptic currents. A
single author (JKYL) blinded to the measured cell types confirmed
currents and tracings. Measurements that had capacitive transient
less than 1000 pA or access resistance that varied by 20% as
measured during a 10 mV voltage-step uncompensated recording
were excluded. Due to the conditions of co-culture and presence of
multiple cell types, unbiased techniques of cell selection for
electrophysiology could not be used. Consequently, we report the
activity of cells as a percentage of all cells recorded from, as
described. No difference was seen between Noggin- and EGF-
treated groups, and data were pooled.
Statistical analyses
Analyses were performed using Microsoft Excel software
(Microsoft, Seattle WA) and statistically analyzed using SAS
software (SAS Institute Inc, Cary CA). Quantitative Real-time
RT-PCR was analysed for significance with normalized, calibrated
expression ratios determined by one-way ANOVA statistical test
with Tukey and Tukey-Kramer post hoc multiple comparison
algorithms. Heterogeneous data sets (typically with values ,0.01)
were transformed prior to analysis. Electrophysiological results
were analysed with non-parametric Kruskal-Wallis one-way
ANOVA by ranks (p,0.05), followed by Kruskal-Wallis or Chi-
square multiple comparisons (p,0.05) and/or the Kolmogorov-
Smirnov test for differences between distributions (p,0.05).
Results are stated in mean +/2 SEM: *, p,0.05; **, p,0.01.
Supporting Information
Table S1 Antibody detail and canine-specific immuno-
reactivity.
(PDF)
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